Article
21 May 2025
The Trump Administration Continues Focus On Drug Pricing With "Most-Favored-Nation Prescription Drug Pricing" Executive Order
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
17 Feb 2025
2025 Perspectives In Private Equity: Health Care & Life Sciences
Video
21 Nov 2024
Health Care & Life Sciences - Outlook For The 119th Congress & The Trump Administration
Article
19 Nov 2024
Lame Duck Agenda
Article
11 Jul 2024
Chevron Runs Out Of Gas: The Bumpy Road Ahead For Health Regulations After Loper Bright
Article
31 May 2024
Anti-Obesity Medications: Noteworthy Developments As Policymakers Weigh Coverage Considerations
Article
09 May 2024
FDA Finalizes LDT Regulation, With Significant Exceptions: Enforcement Of Requirements Will Phase In Over Four Years
Article
01 May 2024
Analysis: CY 2025 Revisions To Medicare Advantage And Part D Rules Governing Agent, Broker And Third Party Compensation
Article
01 May 2024
The Regulatory Race Is On: The Biden Administration Sprints To Issue Key Health Policies
Article
20 Mar 2024
CMS Revises Policy On Texting Patient Orders